While HCA Healthcare Inc has overperformed by 6.05%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HCA rose by 19.03%, with highs and lows ranging from $417.14 to $279.93, whereas the simple moving average fell by -3.67% in the last 200 days.
On December 17, 2024, JP Morgan started tracking HCA Healthcare Inc (NYSE: HCA) recommending Neutral. A report published by Wells Fargo on November 25, 2024, Downgraded its rating to ‘Underweight’ for HCA. KeyBanc Capital Markets Initiated an Overweight rating on October 11, 2024, and assigned a price target of $475. Morgan Stanley initiated its ‘Equal-Weight’ rating for HCA, as published in its report on September 03, 2024. Robert W. Baird’s report from May 30, 2024 suggests a price prediction of $396 for HCA shares, giving the stock a ‘Outperform’ rating. Barclays also rated the stock as ‘Overweight’.
Analysis of HCA Healthcare Inc (HCA)
The current dividend for HCA investors is set at $2.64 per share, indicating investors will get a return regardless of how the company performs over the next quarter. Further, the quarter-over-quarter increase in sales is 5.68%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of HCA Healthcare Inc’s future performance, with equity being one of the most critical indicators. Taking into account the quick ratio of the company, currently set at 0.97, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and HCA is recording an average volume of 1.56M. On a monthly basis, the volatility of the stock is set at 2.61%, whereas on a weekly basis, it is put at 3.84%, with a gain of 6.94% over the past seven days. Furthermore, long-term investors anticipate a median target price of $382.32, showing growth from the present price of $332.00, which can serve as yet another indication of whether HCA is worth investing in or should be passed over.
How Do You Analyze HCA Healthcare Inc Shares?
HCA Healthcare Inc (HCA) is based in the USA and is one of the most prominent companies operating in the Medical Care Facilities market. When comparing HCA Healthcare Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 15.10, there is a growth in quarterly earnings of -4.95%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 28.54%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 64.14% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
HCA shares are owned by institutional investors to the tune of 64.14% at present.
